全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

Melanoregulin, Product of the dsu Locus, Links the BLOC-Pathway and Oa1 in Organelle Biogenesis

DOI: 10.1371/journal.pone.0042446

Full-Text   Cite this paper   Add to My Lib

Abstract:

Humans with Hermansky-Pudlak Syndrome (HPS) or ocular albinism (OA1) display abnormal aspects of organelle biogenesis. The multigenic disorder HPS displays broad defects in biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lysosomes. A phenotype of ocular pigmentation in OA1 is a smaller number of macromelanosomes, in contrast to HPS, where in many cases the melanosomes are smaller than normal. In these studies we define the role of the Mregdsu gene, which suppresses the coat color dilution of Myo5a, melanophilin, and Rab27a mutant mice in maintaining melanosome size and distribution. We show that the product of the Mregdsu locus, melanoregulin (MREG), interacts both with members of the HPS BLOC-2 complex and with Oa1 in regulating melanosome size. Loss of MREG function facilitates increase in the size of micromelanosomes in the choroid of the HPS BLOC-2 mutants ruby, ruby2, and cocoa, while a transgenic mouse overexpressing melanoregulin corrects the size of retinal pigment epithelium (RPE) macromelanosomes in Oa1ko/ko mice. Collectively, these results suggest that MREG levels regulate pigment incorporation into melanosomes. Immunohistochemical analysis localizes melanoregulin not to melanosomes, but to small vesicles in the cytoplasm of the RPE, consistent with a role for this protein in regulating membrane interactions during melanosome biogenesis. These results provide the first link between the BLOC pathway and Oa1 in melanosome biogenesis, thus supporting the hypothesis that intracellular G-protein coupled receptors may be involved in the biogenesis of other organelles. Furthermore these studies provide the foundation for therapeutic approaches to correct the pigment defects in the RPE of HPS and OA1.

References

[1]  O'Sullivan TN, Wu XS, Rachel RA, Huang JD, Swing DA, et al. (2004) dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice. Proc Natl Acad Sci U S A 101: 16831–16836.
[2]  Matesic LE, Yip R, Reuss AE, Swing DA, O'Sullivan TN, et al. (2001) Mutations in Mlph, encoding a member of the Rab effector family, cause the melanosome transport defects observed in leaden mice. Proc Natl Acad Sci USA 98: 10238–10243.
[3]  Wilson SM, Yip R, Swing DA, O'Sullivan TN, Zhang Y, et al. (2000) A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci USA 97: 7933–7938.
[4]  Di Pietro SM, Dell'Angelica EC (2005) The cell biology of Hermansky-Pudlak syndrome: recent advances. Traffic 6: 525–533.
[5]  Gunay-Aygun M, Huizing M, Gahl W (2004) Molecular defects that affect platelet dense granules. Semin Thromb Hemost 30: 537–547.
[6]  Schnur RE, Wick PA, Bailey C, Rebbeck T, Weleber RG, et al. (1995) Phenotypic variability in X-linked ocular albinism: relationship to linkage genotypes. Am J Hum Genet 1994 55: 484–496.
[7]  Oetting WS, King RA (1999) Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 13: 99–115.
[8]  Young A, Jiang M, Wang Y, Ahmedli NB, Ramirez J, et al. (2011) Specific interaction of Galphai3 with the Oa1 G-protein coupled receptor controls the size and density of melanosomes in retinal pigment epithelium. PloS one 6: e24376.
[9]  Moore KJ, Swing DA, Rinchik EM, Mucenski ML, Buchberg AM, et al. (1988) The murine dilute suppressor gene dsu suppresses the coat-color phenotype of three pigment mutations that alter melanocyte morphology, d, ash and ln. Genetics 119: 933–941.
[10]  Moore KJ, Seperack PK, Strobel MC, Swing DA, Copeland NG, et al. (1988) Dilute suppressor dsu acts semidominantly to suppress the coat color phenotype of a deletion mutation, dl20J, of the murine dilute locus. Proc Natl Acad Sci USA 85: 8131–8135.
[11]  Sweet HO (1983) Dilute suppressor, a new suppressor gene in the house mouse. J Hered 74: 305–306.
[12]  Wu X, Wang F, Rao K, Sellers JR, Hammer JA 3rd (2002) Rab27a is an essential component of melanosome receptor for myosin Va. Mol Biol Cell 13: 1735–1749.
[13]  Wu XS, Rao K, Zhang H, Wang F, Sellers JR, et al. (2002) Identification of an organelle receptor for myosin-Va. Nat Cell Biol 4: 271–278.
[14]  Ohbayashi N, Maruta Y, Ishida M, Fukuda M (2012) Melanoregulin regulates retrograde melanosome transport through interaction with the RILP-p150Glued complex in melanocytes. Journal of Cell Science 125: 1508–1518.
[15]  Anikster Y, Huizing M, White J, Shevchenko YO, Fitzpatrick DL, et al. (2001) Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 28: 376–380.
[16]  Gardner JM, Wildenberg SC, Keiper NM, Novak EK, Rusiniak ME, et al. (1997) The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci USA 94: 9238–9243.
[17]  Gwynn B, Ciciotte SL, Hunter SJ, Washburn LL, Smith RS, et al. (2000) Defects in the cappuccino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky-Pudlak syndrome by an AP-3-independent mechanism. Blood 96: 4227–4235.
[18]  Gwynn B, Martina JA, Bonifacino JS, Sviderskaya EV, Lamoreux ML, et al. (2004) Reduced pigmentation (rp), a mouse model of Hermansky-Pudlak syndrome, encodes a novel component of the BLOC-1 complex. Blood 104: 3181–3189.
[19]  Suzuki T, Li W, Zhang Q, Karim A, Novak EK, et al. (2002) Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene. Nat Genet 30: 321–324.
[20]  Suzuki T, Li W, Zhang Q, Novak EK, Sviderskaya EV, et al. (2001) The gene mutated in cocoa mice, carrying a defect of organelle biogenesis, is a homologue of the human Hermansky-Pudlak syndrome-3 gene. Genomics 78: 30–37.
[21]  Suzuki T, Oiso N, Gautam R, Novak EK, Panthier JJ, et al. (2003) The mouse organellar biogenesis mutant buff results from a mutation in Vps33a, a homologue of yeast vps33 and Drosophila carnation. Proc Natl Acad Sci USA 100: 1146–1150.
[22]  Zhang Q, Li W, Novak EK, Karim A, Mishra VS, et al. (2002) The gene for the muted (mu) mouse, a model for Hermansky-Pudlak syndrome, defines a novel protein which regulates vesicle trafficking. Hum Mol Genet 11: 697–706.
[23]  Zhang Q, Zhao B, Li W, Oiso N, Novak EK, et al. (2003) Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat Genet 33: 145–153.
[24]  Zhen L, Jiang S, Feng L, Bright NA, Peden AA, et al. (1999) Abnormal expression and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to platelet storage pool deficiency in the pearl mouse. Blood 94: 146–155.
[25]  Nguyen T, Novak EK, Kermani M, Fluhr J, Peters LL, et al. (2002) Melanosome morphologies in murine models of hermansky-pudlak syndrome reflect blocks in organelle development. J Invest Dermatol 119: 1156–1164.
[26]  Nguyen T, Wei ML (2004) Characterization of melanosomes in murine Hermansky-Pudlak syndrome: mechanisms of hypopigmentation. J Invest Dermatol 122: 452–460.
[27]  Di Pietro SM, Falcon-Perez JM, Dell'Angelica EC (2004) Characterization of BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3, HPS5 and HPS6. Traffic 5: 276–283.
[28]  Gautam R, Chintala S, Li W, Zhang Q, Tan J, et al. (2004) The Hermansky-Pudlak syndrome 3 (cocoa) protein is a component of the biogenesis of lysosome-related organelles complex-2 (BLOC-2). J Biol Chem 279: 12935–12942.
[29]  Helip-Wooley A, Westbroek W, Dorward H, Mommaas M, Boissy RE, et al. (2005) Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin. BMC Cell Biol 6: 33.
[30]  Theos AC, Tenza D, Martina JA, Hurbain I, Peden AA, et al. (2005) Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes. Mol Biol Cell 16: 5356–5372.
[31]  Hearing VJ (2005) Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci 37: 3–14.
[32]  Bassi MT, Incerti B, Easty DJ, Sviderskaya EV, Ballabio A (1996) Cloning of the murine homolog of the ocular albinism type 1 (OA1) gene: sequence, genomic structure, and expression analysis in pigment cells. Genome Res 6: 880–885.
[33]  Newton JM, Orlow SJ, Barsh GS (1996) Isolation and characterization of a mouse homolog of the X-linked ocular albinism (OA1) gene. Genomics 37: 219–225.
[34]  Schiaffino MV, Baschirotto C, Pellegrini G, Montalti S, Tacchetti C, et al. (1996) The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. Proc Natl Acad Sci USA 93: 9055–9060.
[35]  Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, et al. (1999) Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat Genet 23: 108–112.
[36]  Staleva L, Orlow SJ (2006) Ocular albinism 1 protein: trafficking and function when expressed in Saccharomyces cerevisiae. Exp Eye Res 82: 311–318.
[37]  Innamorati G, Piccirillo R, Bagnato P, Palmisano I, Schiaffino MV (2006) The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. Pigment Cell Res 19: 125–135.
[38]  Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS (2008) L-DOPA is an endogenous ligand for OA1. PLoS Biol 6: e236.
[39]  Giordano F, Bonetti C, Surace EM, Marigo V, Raposo G (2009) The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition. Human Molecular Genetics 18: 4530–4545.
[40]  Incerti B, Cortese K, Pizzigoni A, Surace EM, Varani S, et al. (2000) Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1. Hum Mol Genet 9: 2781–2788.
[41]  Cortese K, Giordano F, Surace EM, Venturi C, Ballabio A, et al. (2005) The ocular albinism type 1 (OA1) gene controls melanosome maturation and size. Invest Ophthalmol Vis Sci 46: 4358–4364.
[42]  LaVail JH, Nixon RA, Sidman RL (1978) Genetic control of retinal ganglion cell projections. J Comp Neurol 182: 399–421.
[43]  Balkema GW, Drager UC (1990) Origins of uncrossed retinofugal projections in normal and hypopigmented mice. Vis Neurosci 4: 595–604.
[44]  Damek-Poprawa M, Diemer T, Lopes VS, Lillo C, Harper DC, et al. (2009) Melanoregulin (MREG) modulates lysosome function in pigment epithelial cells. J Biol Chem 284: 10877–10889.
[45]  Samaraweera P, Shen B, Newton JM, Barsh GS, Orlow SJ (2001) The mouse ocular albinism 1 gene product is an endolysosomal protein. Exp Eye Res 72: 319–329.
[46]  Shen B, Rosenberg B, Orlow SJ (2001) Intracellular distribution and late endosomal effects of the ocular albinism type 1 gene product: consequences of disease-causing mutations and implications for melanosome biogenesis. Traffic 2: 202–211.
[47]  Shen B, Samaraweera P, Rosenberg B, Orlow SJ (2001) Ocular albinism type 1: more than meets the eye. Pigment Cell Res 14: 243–248.
[48]  Rachel RA, Dolen G, Hayes NL, Lu A, Erskine L, et al. (2002) Spatiotemporal features of early neuronogenesis differ in wild-type and albino mouse retina. J Neurosci 22: 4249–4263.
[49]  McGinness J, Corry P, Proctor P (1974) Amorphous semiconductor switching in melanins. Science 183: 853–855.
[50]  Tobin GJ, Nagashima K, Gonda MA (1996) Immunologic and Ultrastructural Characterization of HIV Pseudovirions Containing Gag and Env Precursor Proteins Engineered in Insect Cells. Methods 10: 208–218.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133